Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast

Histochemistry and Cell Biology

Volumn 139, Issue 1, 2013, Pages 161-171

  Boström, Pia ^a   Sainio, Annele ^b   Kakko, Tanja ^b   Savontaus, Mikko ^a   Söderström, Mirva ^a   Järveläinen, Hannu ^a,b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Breast cancer; Cell behavior; Decorin; Extracellular matrix; In situ hybridization

Indexed keywords

ADENOVIRUS VECTOR; DECORIN; DIGOXIGENIN;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST PAPILLOMA; CANCER INVASION; CARCINOMA IN SITU; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INTRADUCTAL CARCINOMA; LOBULAR CARCINOMA IN SITU; MAJOR CLINICAL STUDY; MYOEPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RNA PROBE; SIGNAL TRANSDUCTION; STROMA CELL; TRANSCRIPTOMICS;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA; CELL ADHESION; CELL PROLIFERATION; DECORIN; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; MCF-7 CELLS; MIDDLE AGED; RNA, MESSENGER; STROMAL CELLS; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 84872334921     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-012-1026-0     Document Type: Article

References (57)

1. Al Haj Zen A, Lafont A, Durand E et al (2003) Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts. Matrix Biol 22:251-258 (Pubitemid 36802367)
2. Alowami S, Troup S, Al-Haddad S et al (2003) Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 5:R129-R135
3. Araki K, Wakabayashi H, Shintani K et al (2009) Decorin suppresses bone metastasis in a breast cancer cell line. Oncology 77:92-99
4. Biaoxue R, Xiguang C, Hua L et al (2011) Decreased expression of decorin and p57(KIP2) correlates with poor survival and lymphatic metastasis in lung cancer patients. Int J Biol Markers 26:9-21
5. Boström P, Söderström M, Palokangas T et al (2009) Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors. BMC Res Notes 2:140
6. Brown LF, Guidi AJ, Schnitt SJ et al (1999) Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 5:1041-1056 (Pubitemid 29233218)
7. Burdall SE, Hanby AM, Lansdown MRJ, Speirs V (2003) Breast cancer cell lines: friend of foe? Breast Cancer Res 5:89-95 (Pubitemid 36348102)
8. Cawthorn TR, Moreno JC, Dharsee M et al (2012) Proteomic Analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival. PLoS One 7:e30992
9. Daley WP, Peters SB, Larsen M (2008) Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 121:255-264 (Pubitemid 351356696)
10. Danielson KG, Baribault H, Holmes DF et al (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136:729-743 (Pubitemid 27083772)
11. Ellis P, Schnitt S, Sastre-Garau X et al (2003) WHO classification of tumours pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon, pp 9-59
12. Eshchenko T, Rykova V, Chernakov A et al (2007) Expression of different proteoglycans in human breast tumors. Biochemistry (Moscow) 72:1016-1020 (Pubitemid 47518859)
13. Ferdous Z, Peterson SB, Tseng H et al (2010) A role for decorin in controlling proliferation, adhesion, and migration of murine embryonic fibroblasts. J Biomed Mater Res A 93:419-428
14. Fisher LW, Termine JD, Young MF (1989) Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 264:4571-4576 (Pubitemid 19081361)
15. Geyer F, Marchio C, Reis-Filho J (2009) The role of molecular analysis in breast cancer. Pathology 41:77-88
16. Goldhirsch A, Ingle JN, Gelber RD et al (2009) Thresholds for therapies: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2009. Ann Oncol 20:1319-1329
17. Goldoni S, Iozzo RV (2008) Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int J Cancer 123:2473-2479
18. Goldoni S, Seidler DG, Heath J et al (2008) An antimetastatic role for decorin in breast cancer. Am J Pathol 173:844-855
19. Goldoni S, Humphries A, Nyström A et al (2009) Decorin is a novel antagonistic ligand of the Met receptor. J Cell Biol 18:743-754
20. Gu Y, Zhang S, Wu Q et al (2010) Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer. J Exp Clin Cancer Res 29:6
21. Guidetti G, Bertoni A, Viola M et al (2002) The small proteoglycan decorin supports adhesion and activation of human platelets. Blood 100:1707-1714 (Pubitemid 34925148)
22. Herman ME, Katzenellenbogen BS (1994) Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. Cancer Res 54:5867-5874 (Pubitemid 24375221)
23. Hielscher AC, Qiu C, Gerecht S (2012) Breast cancer cell-derived matrix supports vascular morphogenesis. Am J Physiol Cell Physiol 302:C1243-C1256
24. Hu Y, Sun H, Owens RT et al (2009) Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways. Neoplasia 11(10):1042-1053
25. Hynes RO (2009) The extracellular matrix: not just pretty fibrils. Science 326:1216-1219
26. Iozzo RV, Sanderson RD (2011) Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med 15:1013-1031
27. Iozzo RV, Schaefer L (2010) Proteoglycans in health and disease: novel regulatory signalling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 277:3864-3875
28. Iozzo RV, Chakrani F, Perrotti D et al (1999) Cooperative action of germline mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc Natl Acad Sci USA 96:3092-3097 (Pubitemid 29148849)
29. Iozzo RV, Buraschi S, Genua M et al (2011) Decorin anatagonizes IGF-IR function by interfering with IGF-IR activity and attenuating downstream signaling. J Biol Chem 286:34712-34721
30. Järveläinen H, Sainio A, Koulu M et al (2009) Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 61:198-223
31. Khan GA, Girish GV, Lala N et al (2011) Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast. Mol Endocrinol 25:1431-1443
32. Kilpinen S, Autio R, Ojala K et al (2008) Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol 9:R139
33. Leygue E, Snell L, Dotzlaw H et al (2000) Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol 2000:313-320
34. Lu P, Weaver VM, Werb Z (2012) The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196:395-406
35. Marastoni S, Ligresti G, Lorenzon E et al (2008) Extracellular matrix: a matter of life and death. Connect Tissue Res 3:203-206
36. Nash MA, Deavers MT, Freedman RS (2002) The expression of decorin in human ovarian tumors. Clin Cancer Res 8:1754-1760 (Pubitemid 34633731)
37. Neill T, Painter H, Buraschi S et al (2012) Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem 287:5492-5506
38. Pucci-Minafra I, Cancemi P, Di Cara G et al (2008) Decorin transfection induces proteomic and phenotypic modulation in breast cancer cells 8701-BC. Connect Tissue Res 49:30-41 (Pubitemid 351298152)
39. Reed CC, Gauldie J, Iozzo RV (2002) Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin. Oncogene 21:3688-3695 (Pubitemid 34620532)
40. Reed CC, Waterhouse A, Kirby S et al (2005) Decorin prevents metastatic spreading of breast cancer. Oncogene 24:1104-1110 (Pubitemid 40313888)
41. Rozario T, DeSimone DW (2010) The extracellular matrix in development and morphogenesis: a dynamic review. Dev Biol 341:126-140
42. Salomäki HH, Sainio AO, Söderström M et al (2008) Differential expression of decorin by human malignant and benign vascular tumors. J Histochem Cytochem 56:639-646 (Pubitemid 351842417)
43. Santra M, Mann DM, Mercer EW et al (1997) Ectopic expression of decorin protein core causes a generilized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest 100:149-157 (Pubitemid 27311253)
44. Seidler DG, Dreier R (2008) Decorin and its galactosaminoglycan chain: extracellular regulator of cellular function? IUBMB Life 60:729-733
45. Seidler DG, Goldoni S, Agnew C et al (2006) Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem 281:26408-26418 (Pubitemid 44401849)
46. Shintani K, Matsumine A, Kusuzaki K et al (2008) Decorin suppresses lung metastases of murine osteosarcoma. Oncol Rep 19:1533-1539
47. Skandalis SS, Labropoulou VT, Ravazoula P et al (2011) Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas. BMC Cancer 11:314
48. Theocharis AD, Skandalis SS, Tzanakakis GN, Karamanos NK (2010) Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J 277:3904-3923
49. Tralhão JG, Schaefer L, Micegova M et al (2003) In vivo selective and distant killing of cancer cells, using adenovirus-mediated decorin gene transfer. FASEB J 17:464-466
50. Troup S, Njue C, Kliewer EV et al (2003) Reduced expression of small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res 9:207-214 (Pubitemid 36109735)
51. Wilcox JN (1993) Fundamental principles of in situ hybridization. J Histochem Cytochem 41:1725-1733 (Pubitemid 23342385)
52. Wilkinson GW, Akrigg A (1992) Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res 20:2233-2239
53. Winnemöller M, Schmidt G, Kresse H (1991) Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol 34:10-17
54. Winnemöller M, Schön P, Vischer P, Kresse H (1992) Interactions between thrombospondin and small proteoglycan decorin: interference with cell attachment. Eur J Cell Biol 59:47-55
55. World Health Organization Fact sheet N334, November 2009
56. Yamaguchi Y, Mann DM, Ruoslahti E (1990) Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346:281-284 (Pubitemid 20227409)
57. Zhang X, Ding L, Sandford AJ (2005) Selection of reference genes for gene expression studies in human neutrophils by real-time PCR. BMC Mol Biol 6:4 (Pubitemid 41418210)